International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Melatonin 2-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Page(s): 512

Melatonin 2-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Melatonin 2-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, melatonin, central nervous system agents, CNS depressant, antioxidant, circadian rhythm disturbances, sleep disorders, jet lag, delayed sleep phase syndrome, rapid eye movement sleep behavior disorder, insomnia, high blood pressure, hypertension, pain relief, analgesic, endogenous hormone, medicinal plant

Related Categories: FORMULATIONS, PAIN MANAGEMENT, CARDIOLOGY, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Melatonin 2-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 512
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Riepl Mike	Jan/Feb 2022 Pg. 18-23
Melatonin 1-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2011 Pg. 246
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Allen Loyd V Jr	Jan/Feb 2020 Pg. 62
Sleepless in America: Compounding with Melatonin Wynn Tom, Rawlings Kate	Jan/Feb 2010 Pg. 10-13
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez	Jan/Feb 2022 Pg. 6-8
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Logomasini Mark A, Stout Richard R, Ron Marcinkoski	Jul/Aug 2013 Pg. 270-280
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I	Nov/Dec 2009 Pg. 506-515
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H	Sep/Oct 2014 Pg. 418-426
Return to Top